Literature DB >> 9802957

Effects of S-salbutamol on human isolated bronchus.

A G Templeton1, I D Chapman, E R Chilvers, J Morley, D A Handley.   

Abstract

A range of stimuli have been used to determine the effect of S-salbutamol on contractile responses of human isolated bronchus. Significant augmentation of contraction was evident during responses to histamine or LTC4 but responses to EFS, methacholine, bradykinin and capsaicin were not influenced and allergic bronchospasm was significantly impaired by prior exposure to S-salbutamol. Since R-salbutamol relaxes human isolated bronchus, the capacity of S-salbutamol to enhance contractile responses to histamine or LTC4 cannot be attributed to activation of beta2-adrenoceptors. It is concluded, therefore, that these effects of S-salbutamol represent distinct pharmacological actions of the distomer. It is also suggested that the capacity of S-salbutamol to augment contraction of airway smooth muscle may contribute to hyperreactivity towards spasmogens when racemic salbutamol is used for symptom relief in asthma and chronic obstructive pulmonary disease (COPD). Copyright 1998 Academic Press

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9802957     DOI: 10.1006/pupt.1998.0110

Source DB:  PubMed          Journal:  Pulm Pharmacol Ther        ISSN: 1094-5539            Impact factor:   3.410


  16 in total

1.  Effects of (r,r)- and (r,r/s,s)-formoterol on airway relaxation and contraction in an experimental rat model.

Authors:  Maroun J Mhanna; Jeffrey F Koester; Robert C Cohn
Journal:  Curr Ther Res Clin Exp       Date:  2007-07

2.  Guidelines for diagnosis and management of bronchial asthma: Joint ICS/NCCP (I) recommendations.

Authors:  Ritesh Agarwal; Sahajal Dhooria; Ashutosh Nath Aggarwal; Venkata N Maturu; Inderpaul S Sehgal; Valliappan Muthu; Kuruswamy T Prasad; Lakshmikant B Yenge; Navneet Singh; Digambar Behera; Surinder K Jindal; Dheeraj Gupta; Thanagakunam Balamugesh; Ashish Bhalla; Dhruva Chaudhry; Sunil K Chhabra; Ramesh Chokhani; Vishal Chopra; Devendra S Dadhwal; George D'Souza; Mandeep Garg; Shailendra N Gaur; Bharat Gopal; Aloke G Ghoshal; Randeep Guleria; Krishna B Gupta; Indranil Haldar; Sanjay Jain; Nirmal K Jain; Vikram K Jain; Ashok K Janmeja; Surya Kant; Surender Kashyap; Gopi C Khilnani; Jai Kishan; Raj Kumar; Parvaiz A Koul; Ashok Mahashur; Amit K Mandal; Samir Malhotra; Sabir Mohammed; Prasanta R Mohapatra; Dharmesh Patel; Rajendra Prasad; Pallab Ray; Jai K Samaria; Potsangbam Sarat Singh; Honey Sawhney; Nusrat Shafiq; Navneet Sharma; Updesh Pal S Sidhu; Rupak Singla; Jagdish C Suri; Deepak Talwar; Subhash Varma
Journal:  Lung India       Date:  2015-04

Review 3.  The pharmacokinetics of levosalbutamol: what are the clinical implications?

Authors:  D W Boulton; J P Fawcett
Journal:  Clin Pharmacokinet       Date:  2001-01       Impact factor: 6.447

4.  Bronchopulmonary pharmacokinetics of (R)-salbutamol and (S)-salbutamol enantiomers in pulmonary epithelial lining fluid and lung tissue of horses.

Authors:  Glenn A Jacobson; Sharanne Raidal; Kate Robson; Christian K Narkowicz; David S Nichols; E Haydn Walters
Journal:  Br J Clin Pharmacol       Date:  2017-02-08       Impact factor: 4.335

Review 5.  Long-Acting β2-Agonists in Asthma: Enantioselective Safety Studies are Needed.

Authors:  Glenn A Jacobson; Sharanne Raidal; Morten Hostrup; Luigino Calzetta; Richard Wood-Baker; Mark O Farber; Clive P Page; E Haydn Walters
Journal:  Drug Saf       Date:  2018-05       Impact factor: 5.606

6.  (R)-albuterol elicits antiinflammatory effects in human airway epithelial cells via iNOS.

Authors:  Brian N Chorley; Yuehua Li; Shijing Fang; Jin-Ah Park; Kenneth B Adler
Journal:  Am J Respir Cell Mol Biol       Date:  2005-09-29       Impact factor: 6.914

7.  Levosalbutamol vs racemic salbutamol in the treatment of acute exacerbation of asthma.

Authors:  Ajay Punj; Ashish Prakash; Ashu Bhasin
Journal:  Indian J Pediatr       Date:  2009-11       Impact factor: 1.967

8.  Recruitment of β-arrestin 1 and 2 to the β2-adrenoceptor: analysis of 65 ligands.

Authors:  Timo Littmann; Martin Göttle; Michael T Reinartz; Solveig Kälble; Irving W Wainer; Takeaki Ozawa; Roland Seifert
Journal:  J Pharmacol Exp Ther       Date:  2015-08-25       Impact factor: 4.030

9.  Levalbuterol versus albuterol.

Authors:  Bill T Ameredes; William J Calhoun
Journal:  Curr Allergy Asthma Rep       Date:  2009-09       Impact factor: 4.806

10.  Randomized placebo controlled assessment of airway inflammation due to racemic albuterol and levalbuterol via exhaled nitric oxide testing.

Authors:  John F Freiler; Rajiv Arora; Thomas C Kelley; Larry Hagan; Patrick F Allan
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.